Premium
The incorporation of the A2 protein to produce novel Qβ virus‐like particles using cell‐free protein synthesis
Author(s) -
Smith Mark T.,
Varner Chad T.,
Bush Derek B.,
Bundy Bradley C.
Publication year - 2011
Publication title -
biotechnology progress
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 129
eISSN - 1520-6033
pISSN - 8756-7938
DOI - 10.1002/btpr.744
Subject(s) - cell free protein synthesis , coat protein , protein engineering , virus like particle , protein biosynthesis , population , bacteriophage , chemistry , virus , nanotechnology , biology , materials science , biochemistry , enzyme , virology , gene , recombinant dna , escherichia coli , rna , demography , sociology
Virus‐like particles (VLPs) have been employed for a number of nanometric applications because they self‐assemble, exhibit a high degree of symmetry, and can be genetically and chemically modified. However, high symmetry does not allow for a single unique modification site on the VLP. Here, we demonstrate the co‐expression of the cytotoxic A2 protein and the coat protein of the bacteriophage Qβ to form a nearly monodispersed population of novel VLPs. Cell‐free protein synthesis allows for direct access and optimization of protein‐synthesis and VLP‐assembly. The A2 is shown to be incorporated at high efficiency, approaching a theoretical maximum of one A2 per VLP. This work demonstrates de novo production of a novel VLP, which contains a unique site that has the potential for future nanometric engineering applications. © 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom